New generation heart valve system approved by the US FDA
Release date: 2015-07-09 Medtronic today announced that its new recyclable, self-expanding CoreValve Evolut R transcatheter aortic valve replacement system has been approved by the US Food and Drug Administration (FDA) and is available in the United States. Medtronic is a medical technology company from the United States that provides lifelong treatment solutions for patients with chronic diseases. Its main products cover cardiovascular diseases, sports disorders, diabetes, gastrointestinal diseases, urinary system diseases, spinal diseases, nervous system diseases and facial features. Surgery and other fields. According to the China Economic Net reporter, the Evolut R transcatheter aortic valve replacement system is the first and currently recyclable, repositionable heart valve system on the US market, approved for high risk of thoracotomy or Transcatheter aortic valve replacement (TAVR) is performed in patients with severe high-risk severe aortic stenosis. Aortic valve stenosis without treatment can lead to serious heart problems, including heart failure, and even death. According to Dr. Mathew Williams, Director of Cardiology, Structural Cardiology and Adult Cardiac Surgery, New York University's Langone Medical Center, New York, CoreValve Evolut R is based on the Medtronic CoreValve system, which has been used in more than 60 countries in more than 7 countries. The proven clinical use and successful surgical procedures of the 5,000 patients are the basis for the development of the new generation CoreValve Evolut R. It is reported that Mathew Williams is also the co-primary researcher of the CoreValve Evolut R registration test. He stressed: "The TAVR procedure has become an effective treatment option for patients with high-risk aortic stenosis who cannot be treated with thoracotomy. Physicians are looking forward to medical advances that will provide patients with better prognostic outcomes. Clinical data have also confirmed that patients have the best prognosis when the heart valve is properly positioned. Therefore, the technological advances of the recyclable Evolut R system make physicians more confident during surgery, an advantage in other TAVI surgical systems. No." According to the China Economic Net reporter, CoreValve Evolut R transcatheter aortic valve replacement system (23 mm, 26 mm and 29 mm) and CoreValve EnVeo R catheter delivery system have been listed in the US market, and have been in Europe and other Countries and regions that recognize EU CE certification are available. The new generation system consists of the CoreValve Evolut R transcatheter valve and the EnVeo R delivery system, where the delivery system is equipped with an InLine sheath that significantly reduces the circumference of the instrument's access to the smallest size on the market (equivalent to a 14Fr circumference). Products less than 1/5 inches, about 4.62 mm). The smaller delivery system circumference provides treatment potential for patients with smaller vessel diameters (minimum to 5.0 mm), and the risk of severe vascular complications can be minimized by the patient's more acceptable transfemoral access. As the first self-expanding, retrievable transcatheter cardiac main valve system on the US market, the Evolut R approval is the latest in several major milestones that Medtronic has achieved in the TAVR market in recent months. In March 2015, the CoreValve system became the first system in the United States to be approved for surgical aortic valve replacement, and patients with surgical valve damage were treated with a paravalvular valve (VIV). Also at the 2015 American Society of Cardiology Annual Meeting in March of this year, the two-year data release of the highly anticipated CoreValve US key research high-risk patient trial confirmed the use of CoreValve for transcatheter aortic valve replacement compared with surgical aortic valve replacement. Survival benefits are greater. Source: China Economic Net Plant extracts refer to a class of substances derived from plants that have one or more biological functions. Can be separated by physical and chemical extraction of one or more effective components formed by natural products. plant extract,buy plant extract,wholesale plant extract,plant extract benefits,plant extract for sale Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropic.com
There are many kinds of plant extracts. At present, natural plant extracts mainly include essential oils, saponins, alkaloids, polysaccharides, polyphenols, flavonoids and so on. According to the biological activity, it can be divided into antioxidants: grape seed extract, green tea extract, pine bark extract, etc. Immune modulators: ginseng extract, gynostemma pentaphyllum extract, Ganoderma lucidum extract, etc. Improve cardiovascular function: ginkgo biloba extract, lotus seed heart extract, rhodiola extract, etc. Sedative: valerian extract, hop extract and so on.
According to their own characteristics in the market application of plant extracts can be roughly divided into six categories: coloring, seasoning, medicinal, health, dietary supplements and feed additives. Natural plant pigments refer to pigment components in roots, stems, leaves, flowers, fruits and bark of plants, such as turmeric, sappanwood, indigo, safflower, black bean and green walnut peel. Natural plant pigments are widely used in food, textiles, cosmetics, medicine, leather industry, printing and dyeing and other industries.
Plant extracts are rich in ingredients that can effectively stimulate the senses, such as sweeteners and volatile substances. Natural sweeteners, such as stevia glycoside and grosvenin, are popular new sweeteners. They are not only sweet, but also ideal substitutes for sucrose. Essential oils are concentrated volatile substances that are commonly used in the preparation of fragrances and are widely recognized in plant extracts.
Contained in the plant extracts of saponins, alkaloids, polyphenols, flavonoids and other ingredients are widely study has many biological activities, such as antioxidant, antibacterial, anti-inflammatory, improve animal production performance, antivirus, enhance immunity, etc., for human and animal health has the effect of nots allow to ignore, and the development of its pharmacology and health care function has become the main trend of plant extracts.In addition, as a dietary supplement, it is one of the main applications of various plant extracts. Such as oligosaccharides (oligosaccharides, oligosaccharides, oligosaccharides, galactose, etc.) dietary fiber, soybean protein, dietary fiber, wheat albumin, L-arabinose, sugar alcohol (xylitol, malt heavy sugar alcohol, sorbitol, etc.) and other natural plant food additives have been widely used in the food health care market. Many plant functional ingredients with anti-inflammatory, antioxidant and bacteriostatic properties are also commonly used as substitute anti-bacterial products. The application of green feed additives in livestock and poultry production has been vigorously developed, such as green tea polyphenols extract, pine bark procyanidins extract and polyanthocyanidins extract.
Due to the changes in lifestyle, working mode and consumption mode, more consumers are pursuing the life concept of "big health". The so-called "big health" refers to a concept of whole-process, comprehensive and total factor care for people's life around the basic necessities of life, life, old age, illness and death. It not only pursues individual physical and physical health, but also pursues mental, spiritual, social, environmental and family health. In the era of "great health", natural plant-based health products are the core and the key material basis.
With increasing attention to the food and drug safety, from natural plant in the development and utilization of the active ingredient is becoming more and more attention, a large number of food safety, have certain curative effect function of plant extracts have been used as raw materials in a variety of ways into functional food nutrition and health food has entered people's lives, and will play a more and more important role.
And more and more new research new discovery, predicts that the plant extract industry chain will have more members to join, there will be more business opportunities. The future domestic plant extract market will stride forward gradually to mature period!
Shaanxi Yingyuan Xingchuang Biotechnology Co., Ltd. is committed to plant extracts, advanced pharmaceutical intermediates, featured apis, and other customized research and development services; Relying on its GMP production base, it has set up a RESEARCH and development center and GMP pilot workshop to accelerate the commercialization process of production and research. The company has accumulated a number of invention patents, and has been declared by more than ten regulatory bodies such as China, FDA of the United States, EDQM of the European Union, India, Japan, South Korea and Australia. Please feel free to contact us.